CS Paper Radar

Cross-species representation learning aligns mouse and human neural dynamics and tracks clinical drug efficacy

Marko Tvrdic, Justin Richmond Domingo, Jae Ann Buenaluz, Jydell Ashley Palomo Penollar, Edmayelle Villavicencio Alforja, Jobi Fallaeria Subosa, Gabriel Ocana-Santero

cs.LG q-bio.QMq-bio.NC ·submitted 2026-10-08 04:19 UTC · v1

Abstract

Preclinical models poorly predict human drug efficacy, particularly in neurological disorders. Neural activity offers a uniquely rich source of translational information because it captures high-dimensional variation in nervous-system function that can be measured in both animals and humans. However, its high dimensionality makes it difficult to distinguish conserved disease-related features from variation arising from species, recording modality and experimental context. Here, we test whether shared neural dynamics can be identified directly from electrophysiology data by learning representations organized by biological state rather than species. We develop a dual-rule contrastive learning framework that aligns corresponding mouse and human states while preserving separation between distinct phenotypes. This framework recovered conserved sensory-response structure across species and, in epilepsy, resolved distinct relationships between three mouse models and heterogeneous human patient populations. When treated animals were projected into a frozen cross-species representation, drug-induced movement towards the human-aligned healthy state retrospectively tracked known clinical efficacy across ten model-drug combinations including a disease-specific detrimental effect. The framework also identified shared disease-associated neural dynamics between Fmr1-knockout mice and human 16p11.2 copy-number variant carriers despite differences in genetic aetiology and recording modality. Together, these findings show the potential of cross-species neural representation learning to map heterogeneous human disease onto experimentally tractable preclinical states and assess whether interventions restore human-relevant circuit function.

Comment
33 pages, 5 figures; supplementary material included (2 supplementary figures, 3 supplementary tables)

Closest papers

Nearest neighbours by meaning across the whole index.

Neuronal Identity as an Organizational Basis for Analyzing Neural Population Dynamics

cs.LG q-bio.NCeess.SP ·2026-10-27 ·Seungjae Han, Joshua Yedam You, Soi Kim, Minho Eom, Jinho Park +3 more
top venue similarity 0.64
Abstract · Accepted at NeurIPS 2026

Individual neurons exhibit diverse molecular, morphological, and electrophysiological properties that shape their distinct roles in neural circuits. While these multimodal features are largely shared across individuals, they remain an underutilized source of information in analyzing neural population dynamics. We posit that these shared biological profiles provide a common reference for relating neural dynamics across subjects and recording sessions. Our framework leverages this structure by routing neurons into latent groups based on their biological profiles and analyzing population dynamics through group-level representations. Because these assignments are anchored in biological properties that are consistent across subjects, the learned organization supports transfer to unseen animals without retraining or neuron-wise correspondence. We evaluate our framework on whole-brain calcium imaging in larval zebrafish and large-scale electrophysiology in the mouse visual cortex. Across both species and recording modalities, the framework delivers state-of-the-art performance in both neural decoding and manifold analysis: it achieves superior decoding of behavior and stimulus labels while better preserving the temporal consistency and local geometric structure of latent trajectories on unseen data. Our experiments demonstrate that not only does providing biological features improve baseline performance, but our proposed framework achieves even stronger results by using these properties to explicitly structure the population rather than treating them as auxiliary inputs. Together, these results suggest that organizing neural populations by their multimodal biological features offers a promising framework for generalizing population dynamics across subjects and recording sessions.

0.44

CircuitATLAS: Agentic reasoning over a systems neuroscience knowledge graph for target discovery in circuitopathies

cs.AI q-bio.QMq-bio.NC ·2026-10-07 ·Gabriel Ocana-Santero, Marko Tvrdic
similarity 0.62
Abstract · 22 pages, 5 figures, 4 tables

Drug discovery for neurological disease has traditionally centered on the molecules altered by disease. But the molecules that cause pathology are not necessarily the best points from which to reverse it. Here, we ask which otherwise unaltered molecular control points can be engaged to restore pathological neural circuits toward functional states. We present CircuitATLAS, a provenance-grounded systems-neuroscience knowledge graph and agentic framework for target discovery in circuitopathies. It structures literature-derived relationships across diseases, phenotypes, electrophysiology, circuits, brain regions, cell types and molecular effectors, while deliberately excluding direct disease-gene and disease-protein edges to reduce shortcut reasoning. The graph contains 3.83 million nodes and 7.66 million edges, including 5.31 million LLM-extracted relations, and incorporates structured datasets such as the Human Cell Atlas and new multimodal in vivo measurements. We then introduce an agentic workflow that reasons from measurable disease phenotypes through their circuit and cellular substrates to molecular interventions, therapeutic feasibility and clinical constraints. Finally, we introduce a human-governed in vivo lab-in-the-loop linking hypothesis generation to experimental iteration. Within this framework an agent nominated ATP1A3, the neuronal alpha3 Na+/K+-ATPase, as a control point on cortical excitability; interneuron-restricted expression of ATP1A3 abolished the beta- and gamma-band response to a focal 4-aminopyridine challenge in vivo, and the validated target was then carried into a structure-guided small-molecule campaign terminating in a defined assay to resolve the direction of modulation. CircuitATLAS thus provides a framework for discovering therapeutics based not only on what is molecularly disrupted in disease, but on what can be controlled to restore circuit function.

0.34

Language as the Interface: Foundation-Model Contrastive Learning Links Transcriptomes and Electrophysiology

cs.AI ·2026-09-29 ·Junbo Shen, Jinying Gao, Bo Lei
code/data similarity 0.60
Abstract · Code: https://github.com/ai4biomedicine/LangPatch

Integrating transcriptomic and electrophysiological data is essential for building multimodal foundation models for neuroscience. Patch-seq provides paired measurements of gene expression and intrinsic electrophysiology from the same neuron, establishing a basis for training cross-modal models. Here we introduce LangPatch, a foundation-model-based contrastive learning framework that uses paired Patch-seq data to align pretrained GenePT representations with electrophysiological phenotypes through a language-based interface. Gene descriptions and verbalized electrophysiological profiles are embedded by the same frozen text encoder. A context adapter and projection modules connect the modalities through paired contrastive learning. Across mouse visual, mouse motor, and human cortical cohorts, LangPatch achieves the highest mean transcriptome-to-electrophysiology prediction correlation among the evaluated foundation-model and representation-learning methods. It also improves held-out cross-modal alignment in the two mouse cohorts (FOSCTTM 0.107/0.135 vs. 0.208/0.222 for JAMIE, an existing cross-modal Patch-seq imputation method). It predicts transcriptomic family, type, cortical layer, and marker-gene expression from electrophysiology, exceeding other baselines on most endpoints. More importantly, the method transfers across brain areas and species: a model trained on mouse visual cortex predicts electrophysiology in motor cortex with approximately 70% correlation retention and in human cortex with 47% (58% on acute-slice recordings). Together, these results demonstrate alignment between molecular and functional representations of neurons, providing a building block for multimodal foundation models in neuroscience.

0.38

VINCENT: Validated Interaction Network for Cross-drug Explanation of Therapeutics

cs.LG cs.AI ·2026-08-26 ·Fan-Sheng Chuang, Xuchen Li, Yujing Bian, Kaixiong Zhou
similarity 0.59
Abstract · 18 pages, 4 figures

Drug synergy prediction estimates whether two drugs produce a stronger joint effect than expected from their individual activities. For drug combination discovery, a single synergy score is often not enough: researchers also need to know which molecular regions jointly drive the prediction. We study motif-pair synergy explanation, which identifies pairs of chemically coherent regions, one from each drug, that jointly contribute to predicted synergy. Existing interpretable synergy models expose atom- or substructure-level signals, but their explanations are built into the predictor architecture, and none validates cross-drug region scores under repeated perturbations or feeds that evidence back to refine the explanation. A reliable motif-pair explanation should instead be chemically coherent, perturbation-stable, and aligned with predictor behavior. We introduce VINCENT (Validated Interaction Network for Cross-drug Explanation of Therapeutics), a post-training framework for a fixed interaction-aware synergy predictor. VINCENT extracts atom-pair evidence from attention and gradient signals, groups atoms into chemically coherent motifs, and validates candidate motif pairs through repeated local perturbations. The validated evidence is fed back to refine motif assignments, yielding explanations that satisfy these three criteria. On a 25-pair literature-annotated subset, VINCENT achieves a mean motif recall of 0.826 (95% CI: 0.78-0.87), compared with 0.49-0.66 for baselines. Across all 71 test pairs, its validated interaction scores yield a TP/TN separation of 3.36. These results show that closed-loop perturbation validation recovers literature-supported molecular regions more accurately than existing alternatives while producing cross-drug interaction scores that better reflect predictor behavior.

0.16

Disentangled Shared Representations Improve Morpho-Transcriptomic Integration

cs.AI ·2026-08-14 ·Julian Ostermaier, Swann Ruyter, Reuben Dorent, Daniel Racoceanu
similarity 0.59
Abstract

Spatial transcriptomics (ST) enables the simultaneous profiling of gene expression and tissue morphology, creating an opportunity to learn multimodal representations capturing shared morpho-transcriptomic structure. However, standard multimodal models often compress modalities into a common latent space without explicitly separating shared and modality-specific sources of variation, which may limit downstream utility. We investigate whether explicit disentanglement of shared and private latent components improves multimodal representation learning for paired Hematoxylin \& Eosin (H\&E) and ST data. We compare VAE-based and contrastive approaches, each in standard and disentangled variants, across two cancer cohorts under matched experimental conditions. Representations are evaluated using cross-modal reconstruction, downstream probing and cross-modal probe transfer. The experiments suggest two main trends. First, contrastive objectives yield higher downstream probing performance than VAE-based models. Second, disentangled variants improve the selected reconstruction and probing metrics, although the gains depend on the model family, task, direction, and disentanglement strength. Overall, our results suggest that explicitly factorizing shared and modality-specific information can improve multimodal representation learning for spatial transcriptomics and provides a useful evaluation framework for future foundation models.

0.34

Bison: Cross-Dataset Learning for Unseen-Compound Perturbation Prediction

cs.LG cs.AI ·2026-09-26 ·Yunfan Liu, Kasra Ghorbani, Yufei Huang, Zicheng Liu, Jiangbin Zheng +4 more
benchmark similarity 0.59
Abstract

Predicting transcriptional responses to unseen compounds is limited by fragmented chemical coverage and heterogeneous experimental platforms and gene panels. To assess molecular generalization across these settings, we build on Chem-PerturBridge to benchmark eight datasets with 16,771 compounds, withholding test compounds from every training dataset. This comparison reveals that high overall response agreement can coexist with weak prediction of drug-specific differences, despite reproducible signals across repeated measurements. To exploit complementary chemical supervision while targeting these differences, we introduce Bison: a shared gene representation connects native panels, while two discrete diffusion models compose context-dependent responses with molecular deviations learned through matched drug-contrast supervision. A single Bison model jointly trained across all eight datasets achieves the highest mean overall-response and drug-contrast Pearson correlations on the full benchmark in comparison with 11 methods trained independently per dataset. Compared with dataset-specific training of the same architecture, joint training increases mean drug-contrast correlation by 27.4\%, with gains across all eight datasets and improvements in overall response prediction. These results demonstrate how matched drug contrasts turn complementary screens into shared molecular supervision for unseen-drug response prediction while preserving native gene measurements.

0.14

BrainWideBench: Benchmarking large-scale pretraining and across-animal transfer in multi-region neural recordings

cs.LG q-bio.NC ·2026-09-18 ·Alexandre Andre, Shivashriganesh P. Mahato, Vinam Arora, Keshav Balaji, Divyansha Lachi +37 more
benchmark similarity 0.59
Abstract

Advances in large-scale neural recording have made it possible to collect data across many animals and distributed brain regions, raising the question of whether this scale can be exploited to learn general-purpose neural representations transferable across diverse downstream tasks. Yet, progress toward this goal has been limited by fragmented evaluation protocols and a narrow focus on individual task domains. Here, we present BrainWideBench, a benchmark for evaluating across-animal transfer on multi-region neural recordings, built on the International Brain Laboratory Brainwide Map dataset of neural and behavioral recordings spanning 276 brain regions from 139 mice performing a sensory-guided decision-making task. The benchmark is organized around three complementary task suites that evaluate whether learned representations support downstream decoding of behavior, can predict masked or future neural activity, and can recover biologically meaningful anatomical organization. With this benchmark, we systematically evaluate pretraining methods across transfer settings, including finetuning on downstream objectives and zero-shot generalization to unseen animals. Our results confirm pretraining improves performance over matched single-session baselines, but we show current methods exhibit heterogeneity in transfer capabilities: gains depend strongly on the alignment between pretraining objectives and downstream tasks. No single approach performs uniformly well across all three suites, and most methods are designed to only address a subset of them. Together, these findings suggest that learning representations that jointly generalize across behavior, dynamics, and anatomy remains an open challenge. By providing a unified and reproducible evaluation suite, BrainWideBench establishes a framework for measuring progress toward general-purpose models of the mouse brain.

0.40

BiGSyn: A Bi-Level Heterogeneous Graph Contrastive Learning Framework for Interpretable Drug Synergy Prediction

cs.AI ·2026-11-16 ·Senquan Wang, Hui Fang, Haoran Nan, Xingwei Wang, Qiang He
publishedbenchmark similarity 0.58
Abstract · 2026 IEEE International Conference on Data Mining (ICDM 2026)

Drug combination therapy has become a mainstream of modern medicine, with the potential to enhance efficacy, reduce toxicity, and overcome drug resistance. However, identifying synergistic drug combinations remains challenging, as it requires modeling complex interactions across multiple biological scales---from atom-level molecular structures to entity-level relations in biological networks. Existing approaches typically model these levels in isolation, overlooking complementary signals and long-range dependencies. To address these limitations, we propose BiGSyn, a Bi-level heterogeneous Graph contrastive learning framework for drug Synergy prediction. Specifically, BiGSyn leverages heterogeneous graph transformers to extract high-order dependencies from molecular graphs and biological networks, and introduces a bi-level contrastive learning objective to bridge the cross-level semantic gap. Extensive experiments on two benchmark datasets show that BiGSyn consistently outperforms state-of-the-art baselines. Moreover, its attention mechanism highlights key molecular substructures and biological interactions driving synergy, providing interpretable insights.

0.19